Germline mutations in the BRCA1 (MIM# 113705) and BRCA2 (MIM# 600185) genes confer a high lifetime risk of developing breast/ovarian cancer [1] and account for about 16% of the breast cancer familial risk [2]. This evidence concerns the gene BRCA2 and breast cancer.